Will Cannabigerol Trigger Neuroregeneration after a Spinal Cord Injury? An In Vitro Answer from NSC-34 Scratch-Injured Cells Transcriptome
Spinal cord injury affects the lives of millions of people around the world, often causing disability and, in unfortunate circumstances, death. Rehabilitation can partly improve outcomes and only a small percentage of patients, typically the least injured, can hope to return to normal living conditi...
Main Authors: | Andrea Valeri, Luigi Chiricosta, Agnese Gugliandolo, Federica Pollastro, Emanuela Mazzon |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/2/117 |
Similar Items
-
Cannabigerol Activates Cytoskeletal Remodeling via Wnt/PCP in NSC-34: An In Vitro Transcriptional Study
by: Ivan Anchesi, et al.
Published: (2023-01-01) -
Cannabinerol and NSC-34 Transcriptomic Analysis: Is the Dose Who Makes Neuronal Differentiation?
by: Andrea Valeri, et al.
Published: (2022-07-01) -
Cannabichromene Induces Neuronal Differentiation in NSC-34 Cells: Insights from Transcriptomic Analysis
by: Andrea Valeri, et al.
Published: (2023-03-01) -
Transcriptomic Profiling after In Vitro Δ<sup>8</sup>-THC Exposure Shows Cytoskeletal Remodeling in Trauma-Injured NSC-34 Cell Line
by: Luigi Chiricosta, et al.
Published: (2023-09-01) -
Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol
by: Santa Mammana, et al.
Published: (2019-11-01)